コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rmediate (duodenal polyposis) and worst (pre-colectomy).
2 1 years (pulmonary resection) to 78.2 years (colectomy).
3 123 (31%) anti-TNFalpha therapy, and 25 (6%) colectomy.
4 s according to the need for elective partial colectomy.
5 ciated only with variation in use of MIS for colectomy.
6 with intravenous corticosteroids, underwent colectomy.
7 icare expenditures for laparoscopic and open colectomy.
8 th care costs for many operations, including colectomy.
9 percent of clopidogrel-treated patients with colectomy.
10 t hip fracture repair and not after elective colectomy.
11 rged to a nonhome destination after emergent colectomy.
12 t (>/=18 years) patients undergoing elective colectomy.
13 th ulcerative colitis have increased risk of colectomy.
14 associated with a 50% reduction in SSI after colectomy.
15 on and costs up to 1 year following elective colectomy.
16 f 170,789 patients who were readmitted after colectomy.
17 cific postoperative complication rates after colectomy.
18 f stay (LOS), and readmission after elective colectomy.
19 ived adjuvant chemotherapy within 90 days of colectomy.
20 motherapy for colon cancer within 90 days of colectomy.
21 long-term immunosuppressant therapy or total colectomy.
22 st varied from 27% for cystectomy to 40% for colectomy.
23 mends full bowel preparation before elective colectomy.
24 nterostomy closure to 5.3% for open subtotal colectomy.
25 ased infectious complications after elective colectomy.
26 t-level factors associated with variation of colectomy.
27 years of age or older who underwent elective colectomy.
28 time between robotic, laparoscopic, and open colectomy.
29 oglobin, hematocrit, and albumin may predict colectomy.
30 en patients undergoing minimally versus open colectomy.
31 slow-transit constipation may necessitate a colectomy.
32 are needed to optimize patient selection for colectomy.
33 sumption between minimally invasive and open colectomy.
34 factors explaining variation in MIS use for colectomy.
35 ctiveness of open, laparoscopic, and robotic colectomy.
36 igh-grade dysplasia or colorectal cancer) or colectomy.
37 f CRN (inclusive of low-grade dysplasia) and colectomy.
38 sked VTE chemoprophylaxis failures in 18% of colectomies.
39 ; mainly segmental bowel resections and hemi-colectomies.
40 on cancer patients treated with laparoscopic colectomies.
41 t-free chemoprophylaxis in 18% (736/4086) of colectomies.
42 access and 573,435 for non-critical access; colectomy, 10,198 for critical access and 577,680 for no
43 s: laparoscopic colectomy 6% versus 8%, open colectomy 11% versus 14%, laparoscopic proctectomy 13% v
44 day readmission rate for patients undergoing colectomy (12.1% vs 14.1%; P < .001) and hip replacement
46 cement [42 313]; breast lumpectomy [18 018]; colectomy [14 074]; coronary artery bypass graft surgery
47 t study of Medicare beneficiaries undergoing colectomy (189229 patients at 1876 hospitals), coronary
48 286 ileocecal resections (48%), 118 subtotal colectomies (19%), 134 ileal pouch-anal anastomoses (21%
50 f SSIs were 5.4% for appendectomy, 12.1% for colectomy, 2.8% for hysterectomy, and 1.7% for prostatec
51 at a different hospital (AAA repair: 40.5%; colectomy: 25.8%; hip replacement: 32.5%; and pancreatec
53 erwent subtotal colectomy or total abdominal colectomy, 354 (14.3%) underwent total proctocolectomy w
54 lung resection (22.3% MIS), partial or total colectomy (39.1%), enterolysis (19.0% MIS), ileostomy (9
58 st vs highest LOS mode ($26482 vs $29250 for colectomy, $44777 vs $47675 for CABG, and $24553 vs $279
59 ystectomy 2.2% vs. 0.65%, P < 0.001; partial colectomy 5.5% vs. 2.8%, P < 0.001; appendectomy 0.58% v
61 scores, EQ-5D, or SF-6D scores; frequency of colectomy (55 [41%] of 135 patients in the infliximab gr
63 neurysm repair ($60456 vs $23261; P < .001), colectomy ($56787 vs $22853; P < .001), pulmonary resect
64 n each of the operative groups: laparoscopic colectomy 6% versus 8%, open colectomy 11% versus 14%, l
65 tory to corticosteroids, in reducing risk of colectomy, (6) optimal dosing regimens for intravenous c
67 rate was 9.4% after AAA repair, 13.6% after colectomy, 7.5% after hip replacement, and 16.3% after p
68 l pouch-anal anastomoses (21%), 23 segmental colectomies (8%), and 18 abdominoperineal resections (4%
69 ciclosporin group; p=0.223); or mean time to colectomy (811 [95% CI 707-912] days in the infliximab g
70 s for appendectomy (3.8% vs 7.0%; P < .001), colectomy (9.3% vs 15.0%; P < .001), hysterectomy (1.8%
71 (4.1%) underwent AAA repair; 29 388 (22.9%), colectomy; 91 168 (71.2%), hip replacement; and 2276 (1.
73 for a subtotal colectomy or total abdominal colectomy, a total proctocolectomy with end ileostomy, o
75 hed on 31 statements regarding predictors of colectomy, acute severe colitis (ASC), chronically activ
76 owing: colonic perforation, toxic megacolon, colectomy, admission to an intensive care unit for cCDI,
77 lpha (TNFalpha) agents, immunomodulators, or colectomy among those initially treated with intravenous
79 sidered 98,713 patients in 540 hospitals for colectomy and 206,812 patients in 414 hospitals for hip
82 for ulcerative colitis (UC) with concurrent colectomy and Crohn disease (CD) with concurrent small b
83 f disease at the time of IRA, indication for colectomy and having received immunomodulative agents be
84 urgical site infection (SSI) after segmental colectomy and is part of the World Health Organization's
85 patients scheduled for elective laparoscopic colectomy and meeting rigorous criteria for ambulatory s
90 plication, including 2 cases of megacolon, 1 colectomy, and 22 intensive care unit (ICU) admissions.
93 -moderate disease activity, with low risk of colectomy, and are managed by primary care physicians or
95 eatectomy, pulmonary resection, hepatectomy, colectomy, and cystectomy) between 2010 and 2012 were id
98 ntation, more emergent admissions at time of colectomy, and lower survival relative to privately insu
99 riation exists regarding an MIS approach for colectomy, and most of the total variation is attributab
108 is episodes for patients undergoing elective colectomy at 1 of 49 participating hospitals (2010-2013)
109 tients surviving to discharge after emergent colectomy at 3012 hospitals, 46.7% were discharged to a
110 ng gastrectomy, pancreaticoduodenectomy, and colectomy at a 2000-bed urban medical center in Taipei,
111 Medicare enrollees undergoing an elective colectomy at a large tertiary care hospital between Janu
112 nt pancreaticoduodenectomy, hepatectomy, and colectomy at a single academic institution between Septe
117 eneficiaries undergoing laparoscopic or open colectomy between January 1, 2010, and December 31, 2012
118 nt of colon inflammation and higher rates of colectomy, but were not associated with development of a
121 ty score analysis was used to match elective colectomy cases based on primary exposure variable-full
123 ational Surgical Quality Improvement Program colectomy cohort from 2011 to 2012 was performed to exam
124 oportionate share of aggregate costs: 30% in Colectomy (COL), 22% in coronary artery bypass grafting
125 orse and more costly outcomes after elective colectomy compared with patients with CC but better than
126 ients undergoing minimally invasive and open colectomy consume similar amounts of opioid after discha
127 ive either 6 months of adjuvant FOLFOX after colectomy (control) or perioperative FOLFOX for 4 cycles
128 res [abdominal aortic aneurysm (AAA) repair, colectomy, coronary artery bypass grafting (CABG), hip o
129 edicare beneficiaries who underwent elective colectomy, coronary artery bypass grafting, abdominal ao
133 procedures-abdominal aortic aneurysm repair, colectomy, cystectomy, prostatectomy, lung resection, to
134 ational Surgical Quality Improvement Program colectomy data (July 2014-December 2015) and 13 novel ER
135 urgical Quality Improvement Program-targeted colectomy data initiated in 2012 capture information on
139 prior standard for proceeding with elective colectomy following 2 episodes of diverticulitis is no l
140 was used to study emergently performed open colectomies for a primary diagnosis of C difficile colit
143 ive care unit admission after positive test, colectomy for C. difficile infection, or death within 30
144 bdominal aortic aneurysm repair (n = 69207), colectomy for cancer (n = 107647), pulmonary resection (
148 variation in the utilization of laparoscopic colectomy for Medicare patients with colon cancer, sugge
150 iding evidence for the practice of deferring colectomy for patients without persistent symptoms or mu
156 n, $105259 [IQR, $87335-$126541]), and total colectomy for ulcerative colitis (WIQR, $24497; median,
157 eumonectomy, esophagectomy, gastrectomy, and colectomy) for a primary cancer between 2008 and 2012.
161 lt patients who underwent elective segmental colectomy from January 1, 2005, through December 31, 200
162 who underwent elective laparoscopic or open colectomy from January 1, 2010, through December 31, 201
164 rvational study of adult patients undergoing colectomy from January 2017 to May 2018 in the Michigan
166 tegorized according to the procedure volume (colectomy: >=80 cases/yr, proctectomy: >=35/yr, esophage
167 ed diverticulitis, the incidence of elective colectomy has increased dramatically in the last 2 decad
168 t greater odds of dying within 30 days after colectomy, heart valve repair/replacement, or abdominal
170 cholecystectomy HR 1.89, P < 0.001; partial colectomy HR 1.49, P < 0.001; appendectomy HR 1.45, P <
171 ulcerative colitis were at increased risk of colectomy (HR 1.38, 95% CI 1.04 to 1.83) compared to nev
172 n codes were obtained on patients undergoing colectomy, hysterectomy, and knee and hip replacement pr
173 ll-cause 30-day mortality and a composite of colectomy, ICU admission, and/or death attributable to C
174 betes, heart failure) undergoing an elective colectomy in a multipayer national administrative databa
175 grafting, hip replacement, back surgery, or colectomy in IDS-affiliated hospitals compared with thos
176 evidence supporting the use of laparoscopic colectomy in patients with cancer has led to dramatic in
178 ons of UC or the drugs used to treat it) and colectomy in patients with moderate to severe UC compare
179 ine based on 3 or more episodes for elective colectomy increased concurrently with a benchmarking and
182 life-threatening complications and emergency colectomy is particularly high among those patients hosp
185 sion), rectal or ileal pouch polyposis after colectomy (longest projected time), and duodenal polypos
186 sed hospital quality for patients undergoing colectomy, lower extremity bypass, or all surgical proce
187 ences in outcomes between laparoscopic right colectomy (LRC) with intracorporeal ileocolic anastomosi
188 nee replacements) or nontargeted procedures (colectomy, lung resection, abdominal aortic aneurysm rep
189 ancreatectomy, partial or total gastrectomy, colectomy, lung resection, and cystectomy for cancer fro
190 09 Medicare data on beneficiaries undergoing colectomy, lung resection, or coronary artery bypass gra
193 parotomies (mp = 27), and 17.4% of segmental colectomies (mp = 15) recorded as unsupervised during th
194 tients undergoing appendectomy (n = 97,780), colectomy (n = 118,407), hysterectomy (n = 26,639), or r
195 ic colectomy (n = 152,575; median = 4), open colectomy (n = 137,462; median = 7), laparoscopic procte
196 g median day of discharge were: laparoscopic colectomy (n = 152,575; median = 4), open colectomy (n =
198 re beneficiary beneficiaries who underwent a colectomy (n = 88,778, 29.6%), CABG (n = 109,564, 36.6%)
200 Nevertheless, rebleeding requiring subtotal colectomy occurred between 5 h and 6 days after the proc
201 inversely associated with readmission after colectomy (odds ratio [OR], 0.86; 95% CI, 0.79-0.93) but
204 nd most common reason overall (10.3%), after colectomy or proctectomy (18.1%), ventral hernia repair
205 fection (SSI) overall (19.5%) and also after colectomy or proctectomy (25.8%), ventral hernia repair
206 esentative operations: bariatric procedures, colectomy or proctectomy, hysterectomy, total hip or kne
209 of these recommendations on use of elective colectomy or rates of emergency surgery remains undeterm
210 Among these, 950 (38.4%) underwent subtotal colectomy or total abdominal colectomy, 354 (14.3%) unde
211 Procedural Terminology codes for a subtotal colectomy or total abdominal colectomy, a total proctoco
212 i-TNF agent use among patients who underwent colectomy or total proctocolectomy and experienced no si
213 lished in adults for severe CDI resulting in colectomy or transfer to ICU have not been shown to corr
214 selected all patients who underwent elective colectomy or urgent hip fracture repair in French hospit
215 s low SVI county was 10-20% higher following colectomy (OR 1.1 95%CI 1.1-1.2) or CABG (OR 1.2 95%CI 1
216 ng patients from high SVI counties following colectomy (OR 1.1 95%CI 1.1-1.3), CABG (OR 1.4, 95%CI 1.
217 o [OR], 0.52 [95% CI, 0.48-0.58]; P < .001), colectomy (OR, 0.58 [95% CI, 0.55-0.61]; P < .001), hyst
218 d severe CDI (intensive care unit admission, colectomy, or death attributable to CDI within 30 days o
219 (AAA), coronary artery bypass graft (CABG), colectomy, or hip replacement were identified using 100%
220 is process measure in patients who underwent colectomies over 18 months at 36 hospitals in a statewid
221 r postdischarge care use ($4011 vs $5083 for colectomy, P < .001; $6015 vs $6355 for CABG, P = .14; a
222 < .001) or readmissions ($2606 vs $2887 for colectomy, P = .16; $3175 vs $3064 for CABG, P = .67; an
223 onary artery bypass surgery, oesophagectomy, colectomy, pancreatectomy, cholecystectomy, ventral hern
225 dical record data obtained on diverticulitis colectomy patients across a Healthcare Network-wide Colo
236 ords (2005-2008) for all patients undergoing colectomy procedures in the American College of Surgeons
237 ux-en-Y gastric bypass), colorectal surgery (colectomy, proctectomy), or hiatal hernia surgery (parae
239 1, p < 0.001) and for patients who underwent colectomy/proctectomy (C-statistic 0.73, 95%CI 0.72-0.74
240 RAI-A was a fair predictor of mortality for colectomy/proctectomy patients (C-statistic 0.74, 95%CI
241 f 283,545 patients, there were 178,311 (63%) colectomy/proctectomy, 38,167 (14%) pancreaticoduodenect
242 etrospective study of patients who underwent colectomy/proctectomy, coronary artery bypass graft (CAB
247 dures (ie, ventral incisional hernia repair, colectomy, reflux surgery, bariatric surgery, and hyster
248 gement of the retained rectum after subtotal colectomy remains an important issue even in the era of
250 tients (n = 345 surgeons) undergoing partial colectomy reported a risk-adjusted complication rate of
256 relevant to long-term treatment of elective colectomy, stratified differences in risk-adjusted incre
257 ational Surgical Quality Improvement Program Colectomy Targeted Participant Use Data File for 2012 an
258 December 31, 2013, who were included in the Colectomy-Targeted American College of Surgeons National
260 ndectomy, ventral hernia repair, and partial colectomy), the proportion of Zwisch ratings (n = 357) i
261 were no liver metastasis during the primary colectomy, the features of liver imaging can impose char
262 patients who underwent laparoscopic and open colectomy, the key drivers were a reduction in costs fro
263 ve confirmed infectiveness of drainage after colectomy, there is still a controversy after rectal sur
265 t majority of surgeons do not perform enough colectomies to generate a reliable surgeon-specific comp
267 l episode spending in the lowest tertile for colectomy to $5,706 (CI95% $5,506 to $5,906) or 16.1% of
268 varied from 25.2% (range, 6.6% to 100%) for colectomy to 71.2% (range, 8.3% to 100%) for pancreatect
269 for acute kidney injury undergoing elective colectomy to a minimum urine output target of 0.2 mL/kg/
271 went abdominal aortic aneurysm (AAA) repair, colectomy, total hip arthroplasty, and pancreatectomy.
272 ciaries for coronary artery bypass grafting, colectomy, total hip arthroplasty, hip fracture repair,
273 al pouches (surgically created resevoirs) in colectomy-treated patients with ulcerative colitis (UC)
275 ndergoing 4 surgical procedures (2008-2009): colectomy, ventral hernia repair, abdominal aortic aneur
276 throplasty, coronary artery bypass grafting, colectomy, ventral hernia repair, lower extremity vascul
277 rd methods, patients undergoing laparoscopic colectomy (vs open) had lower total Medicare expenditure
278 cteristics, patients undergoing laparoscopic colectomy (vs open) still had lower Medicare expenditure
284 h immunosuppressant (IS) and anti-TNF before colectomy was independently associated with IRA failure
286 queried for scheduled admissions in which a colectomy was performed for neoplastic, diverticular, or
289 ng death, intensive care unit admission, and colectomy, were observed in the laxative and no laxative
290 to CDI, including death, ICU admission, and colectomy, were observed in the laxative and no laxative
291 tis, there was no difference in the need for colectomy when comparing current smokers to never smoker
292 and disease extension over time may predict colectomy, whereas primary sclerosing cholangitis (PSC)
293 OS and in-hospital mortality of laparoscopic colectomy, which suggests that the choice of hospital af
295 xamined all patients who underwent segmental colectomy with anastomosis from 2008 through 2010 partic
298 drink to all patients scheduled for elective colectomy, with the goal of improving patient compliance